Krystal Biotech Inc

NASDAQ:KRYS   4:00:00 PM EDT
177.20
+3.03 (+1.74%)
6:42:07 PM EDT: $178.50 +1.30 (+0.73%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)5.01B
Current PE458.60
Forward PE 79.46
2yr Forward PE 33.82
See more stats
Estimates Current Quarter
Revenue$47.14 Million
Adjusted EPS$0.26
See more estimates
10-Day MA$172.40
50-Day MA$141.95
200-Day MA$123.58
See more pivots

Krystal Biotech Inc Stock, NASDAQ:KRYS

2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania 15203
United States of America
Phone: +1.412.586.5830
Number of Employees: 229

Description

Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.